Donghui Liu
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 4
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 5
- Antioxidant Activity and Oxidative Stress 3
-
- Peroxisome Proliferator-Activated Receptors 4
- Sphingolipid Metabolism and Signaling 3
- Kruppel-like factors research 3
-
- Microbial infections and disease research 4
-
- Acute Kidney Injury Research 3
- Co-authors
- Lemin ZhengJi LiangBing PanXunliang TongYining HuangSubramaniam PennathurDongfeng ChenRudong Deng
- Cited by
- Clinical BiochemistryEndocrinology, Diabetes and MetabolismComplementary and alternative medicine
- Journals
- Veterinary Sciences (2 papers)Journal of Molecular and Cellular Cardiology (2 papers)Cardiovascular Diabetology (2 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Donghui Liu
45 papers receiving 900 citations
Peers
Comparison fields: 5 of 118
- Clinical Biochemistry 71
- Endocrinology, Diabetes and Metabolism 147
- Complementary and alternative medicine 68
- Biochemistry 44
- Cancer Research 87
Countries citing papers authored by Donghui Liu
This map shows the geographic impact of Donghui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghui Liu more than expected).
Fields of papers citing papers by Donghui Liu
This network shows the impact of papers produced by Donghui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghui Liu. The network helps show where Donghui Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donghui Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 9 | |
| 10 | Sericin suppresses high glucose-induced EMT in mouse podocytes via miR-30a-5p and its target Snai1. | 2023 | 1 |
| 11 | 2023 | 10 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 9 | |
| 14 | 2019 | 19 | |
| 15 | 2018 | 40 | |
| 16 | 2013 | 60 | |
| 17 | 2012 | 23 | |
| 18 | 2012 | 40 | |
| 19 | 2011 | 19 | |
| 20 | [The role of protein kinase C alpha in recurrence of superficial bladder carcinoma]. | 2005 | 1 |
About Donghui Liu
Donghui Liu is a scholar working on Fuel Technology, Microbiology and Clinical Biochemistry, having authored 49 papers that have together received 907 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Microbial infections and disease research (4 papers), Advanced Glycation End Products research (4 papers), Antioxidant Activity and Oxidative Stress (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Acute Kidney Injury Research (3 papers) and Kruppel-like factors research (3 papers). The work is most often cited by research in Clinical Biochemistry (71 citations), Endocrinology, Diabetes and Metabolism (147 citations) and Complementary and alternative medicine (68 citations). Donghui Liu has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Lemin Zheng, Ji Liang, Bing Pan, Xunliang Tong, Yining Huang, Subramaniam Pennathur, Dongfeng Chen, Rudong Deng, Yan Wang and Yan Wang. Their work appears in journals such as Veterinary Sciences, Journal of Molecular and Cellular Cardiology, Cardiovascular Diabetology, Frontiers in Pharmacology and Poultry Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.